Ultragenyx Pharmaceutical (RARE.US) — market event timeline

nashnova tracks 1 market event mentioning Ultragenyx Pharmaceutical (RARE.US) as of 2026-11-04, each with a dated one-line analysis of how the event relates to the asset.

1. 2026-11-04AstraZeneca Offers Approximately $10 Billion to Acquire Rare Disease Drugmaker Rhythm

   Pure-play rare metabolic disease company. Big pharma's high-price M&A in the same space may fuel rising market expectations for similar acquisition targets.

For research and information only — not investment advice.